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Abstract—We designed a multi-organ, multi-label 
disease classification algorithm for computed tomography 
(CT) scans using case-level labels from radiology text 
reports.  A rule-based algorithm extracted 19,255 disease 
labels from reports of 13,667 body CT scans from 12,092 
subjects. A 3D DenseVNet was trained to segment 3 organ 
systems: lungs/pleura, liver/gallbladder, and kidneys. From 
patches guided by segmentations, a 3D convolutional 
neural network provided multi-label disease classification 
for normality versus four common diseases per organ. The 
process was tested on 2,158 CT volumes with 2,875 
manually obtained labels. Manual validation of the rule-
based labels confirmed 91 to 99% accuracy. Results were 
characterized using the receiver operating characteristic 
area under the curve (AUC). Classification AUCs for 
lungs/pleura labels were as follows: atelectasis 0.77 (95% 
confidence intervals 0.74 to 0.81), nodule 0.65 (0.61 to 0.69), 
emphysema 0.89 (0.86 to 0.92), effusion 0.97 (0.96 to 0.98), 
and normal 0.89 (0.87 to 0.91). For liver/gallbladder, AUCs 
were: stone 0.62 (0.56 to 0.67), lesion 0.73 (0.69 to 0.77), 
dilation 0.87 (0.84 to 0.90), fatty 0.89 (0.86 to 0.92), and 
normal 0.82 (0.78 to 0.85). For kidneys, AUCs were: stone 
0.83 (0.79 to 0.87), atrophy 0.92 (0.89 to 0.94), lesion 0.68 
(0.64 to 0.72), cyst 0.70 (0.66 to 0.73), and normal 0.79 (0.75 
to 0.83). In conclusion, by using automated extraction of 
disease labels from radiology reports, we created a weakly 
supervised, multi-organ, multi-disease classifier that can 
be easily adapted to efficiently leverage massive amounts 
of unannotated data associated with medical images. 
 
  
Index Terms—Computed Tomography, deep learning, 
multi-label classification, organ segmentation, weak 
supervision, radiology reports.  
I. INTRODUCTION 
HE integration of human and artificial intelligence (AI) has 
the potential to revolutionize disease diagnosis. Ranging 
from the detection of extremely small colonic polyps [1] to 
congenital cataracts in children [2], prospective validation 
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studies suggest that machine learning (ML) could radically 
change how medical images are interpreted. Despite the 
potential, the majority of existing computer aided diagnosis 
(CAD) algorithms for medical imaging target only a single 
organ or disease, making their scope significantly narrower than 
that of clinical practice  [3]-[9].  
Currently, the major bottleneck for developing multi-organ 
CAD algorithms is a lack of annotated data. The traditional 
approach for training these algorithms has relied on a manual 
process of identifying and labeling large numbers of cases. This 
laborious method requires rigorous standardization, clinical 
expertise, and significant time commitment [10]. The hand 
labeling of abnormalities is challenging even for single images 
such as chest radiographs, but the approach becomes even more 
impractical for cross sectional imaging such as computed 
tomography (CT), which can contain upwards of 1,000 
transverse reconstructions per scan.  
 In theory, massive amounts of training data already exist in 
the electronic health record systems of most hospitals. Labels 
for medical images can be extracted from the associated free or 
semi-structured radiology report text form. Although less 
precise than hand labeling, such weak supervision allows the 
systematic processing of vast amounts of existing data. This 
approach has already yielded several large medical imaging 
datasets with varying degrees of labeling [11]-[15]. For CT 
specifically, DeepLesion is a data set mined from the radiology 
report text of almost 11,000 CT studies with over 32,000 lesions 
identified in multiple organs [12, 16, 17]. Faryna et al. used a 
rule-based  algorithm and natural language processing to label 
over 300,000 CT reports for multiple diseases in the 
lungs/pleura, liver, and kidneys [18]. Recently, Draelos et al. 
[19] developed the largest multiple-disease annotated 
volumetric medical imaging data set to date by mining the text 
reports associated with over 36,000 CT volumes to classify 83 
thoracic abnormalities. These studies document the feasibility 
of efficient annotation of large datasets as an enabling step for 
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applying deep learning to medical imaging. 
In this study, we advance prior single-organ work by 
applying weak supervision to provide multi-organ classification 
of body CTs of the chest, abdomen, and pelvis based on existing 
radiology reports. A rule-based algorithm (RBA) was chosen 
because it can rapidly extract labels from large datasets with 
high accuracy and is easily adjustable to tackle new or expanded 
tasks. Additionally, body CTs have great clinical relevance 
because they are performed commonly in clinical practice and 
encompass a variety of organs and diseases within a large 
portion of the body. We focused on three organ systems: 
lungs/pleura, liver/gallbladder, and kidneys; these were chosen 
because they represent large structures with very different 
anatomical appearance, location, and range of disease 
manifestations. We hypothesized that a weak supervision 
framework based on radiology report text would allow a CNN 
model to classify multiple diseases, even without information 
about the disease location or the heterogeneous appearance of 
each organ and disease manifestation. 
 
II. MATERIALS AND METHODS 
A. Disease label and Dataset Mining  
To provide weak supervision, labels were extracted from 
free-text radiology reports stored within our institution’s 
electronic health record. An initial RBA was constructed based 
on the text from 300,000 reports of body CT studies performed 
between 2012 and 2017 within the same electronic health 
record [18]. For this study, the rules were further refined, but 
the design remained unchanged. Reports were composed of 
four free-text sections: scan indication, imaging technique, 
findings, and impression. Our RBA utilized only the findings 
section to limit our labels to image-based information, and to 
minimize the influence of previous medical history that could 
be referenced in other sections. 
Our multiple-organ, multiple-disease framework consisted of 
rules built upon general relationships, which can be applied to 
different organs by adding lists of organ-specific keywords. As 
an example of a simple rule: if a sentence contained the organ 
name “liver” or “hepatic“ and abnormality “lesion,” and there 
was no negation like “no” or “without,” then the label was 
positive for liver lesion. By substituting organ-specific 
keywords, that same rule could be applied to different organs 
and diseases, such as renal atrophy or pleural effusion. 
In order to select disease keywords for lungs/pleura, 
liver/gallbladder, and kidneys, we computed term frequency-
inverse document frequency (TFIDF) for all words associated 
with each organ. We selected reports where the RBA could 
label each organ as positive for any four abnormalities or 
completely normal. The labels were considered “weak” for two 
reasons, because they were applied to the entire volume without 
disease localization, and also because the rule-based decisions 
included some imperfections. For the latter, the label errors 
needed to be small, such that there would be a negligible effect 
when the subsequent classifier is trained on a large number of 
cases. Given thousands or more labels, it would not be practical 
to verify all the labels manually. Therefore to assess the label 
error rate, a subset of reports for each disease keyword was 
manually verified with a sample acceptance process. The model 
was considered acceptable if at least 60 consecutive reports 
TABLE I 
TOTAL NUMBER (#) OF VOLUMES ASSOCIATED WITH EACH LABEL FOR LUNGS/PLEURA, LIVER/GALLBLADDER, AND KIDNEYS (FROM LEFT TO RIGHT). EACH 
VOLUME MAY CONTAIN ONE OR MORE ORGANS AND/OR DISEASE LABELS. NORMAL CASES CONTAIN NO ABNORMALITIES. A TOTAL OF 19,255 LABELS 
FROM 13,667 VOLUMES CONTRIBUTING TO THE DATA WITHIN THIS TABLE, WERE FROM 12,092 UNIQUE SUBJECTS. 
 
Lungs/Pleura Liver/Gallbladder Kidneys 
Label # volumes Label # volumes Label # volumes 
Atelectasis 1,758 Stone 1,088 Stone 1,188 
Nodule 1,628 Lesion 1,716 Lesion 1,685 
Emphysema 1,194 Dilatation 628 Atrophy 683 
Effusion 1,465 Fatty 1,108 Cyst 1,449 
Normal 1,396 Normal 1,123 Normal 1,146 
      
      
 
 
Fig. 1.  Distribution among 3 organs of 19,255 case-level 
labels from 13,667 CT volumes of 12,092 unique subjects. 
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containing each keyword were labeled correctly, such that 
based on the binomial distribution, there was 95% probability 
that the model labeled that disease with ≥95% accuracy. To 
estimate the actual accuracy, all labels in the smaller test set 
were manually validated by a graduate student with gross 
anatomy training (V.M.D.) supervised by a board-certified 
radiologist (G.D.R.). 
This dataset represents a typical clinical cohort, in which 
subjects may undergo multiple scans or have multiple positive 
findings. After applying the RBA, we identified 19,255 case-
level labels in 13,667 CT volumes from 12,092 unique subjects, 
yielding many hundreds to over a thousand cases for each 
disease category. Fig. 1 shows the total dataset and distribution 
of labels, unique subjects, and volumes among each of the 
targeted organs (lungs/pleura, liver/gallbladder, and kidneys). 
Table I shows the number of volumes associated with labels 
used in classification tasks for each of the targeted organs 
(lungs, liver/gallbladder, and kidneys). The lungs/pleura were 
labeled as normal or having one or more of four diseases: 
atelectasis, nodule, emphysema and/or effusion. The 
liver/gallbladder were labeled as normal or stone, lesion, 
dilation, and/or fatty. The kidneys were labeled as normal or 
stone, lesion, atrophy, and/or cyst. These abnormalities were 
selected based on their high prevalence and their varied 
manifestation within the image. Each abnormality or “disease” 
may comprise multiple keywords that were grouped together 
based on similarity of language or overlap in image appearance. 
For example, lung nodule and mass were grouped into the 
nodule class; biliary calculus, calcification, and gallstone to 
liver stone class; and fatty liver and steatosis to fatty liver class. 
The RBA labeled a report as “normal” only in the absence of 
dozens of other diseases that were not otherwise analyzed used 
in this study. Fig. 2 illustrates the co-occurrence and association 
between diseases for this multi-label data set. 
 
B. Image Segmentation 
A segmentation model was used to guide extraction of organ-
specific patches from CT volumes for subsequent classification. 
Fig. 3 shows the overall classification pipeline used in this 
study. The segmentation model was trained with CT volumes 
with organ margins labeled on each transverse section 
originally developed for the 4D extended cardiac-torso (XCAT) 
phantom [20]. Fifty labeled CT volumes were randomly 
assigned into 44 training and 6 validation sets. In the first stage 
of our segmentation study, we implemented three well-known 
CNN architectures: 3D U-net [21], 3D FCN [22]  and 
DenseVNet [23]. Based on the relative accuracy (measured as 
Dice coefficients) of the three architectures, DenseVNet was 
selected as the segmentation model in our workflow. 
Because the XCAT training set contains normal anatomy 
only, segmentation errors were observed when the normally 
aerated lungs were replaced by disease. The segmentation 
model was fine-tuned to address these lung segmentation errors. 
The base segmentation model was used to generate a 
preliminary mask for 30 additional, randomly selected, diseased 
lung cases (10 edema, 10 atelectasis, 7 pneumonia, and 3 
nodule). The resulting segmentation mask was then manually 
corrected to the lung margins. These 30 diseased cases with 
corrected segmentation were combined with 10 normal XCAT 
training cases and used to fine-tune and produce the final 
segmentation model. 
 
C. Weakly Supervised Image Classification 
Prior to classification, all CT volumes were resampled to 
voxels of size 2 mm ´ 2 mm ´  2 mm  via B-spline interpolations, 
 
(a) Lungs/Pleura  
 
(b) Liver/Gallbladder  
 
                                (c) Kidneys 
 
Fig. 2. (a-c) For the lungs/pleura, liver/gallbladder, and 
kidney (respectively), plots show occurrence and co-
occurrence of targeted diseases among unique subjects. Area 
corresponds to frequency for each combination of diseases. 
N= number of unique subjects per organ, n= number of 
unique subjects belonging to that (co-)occurrence. 
Percentage of n/N is noted in parentheses inside each box. 
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clipped to intensity range (-1000, 800) HU for lungs/pleura, 
(-200, 500) HU for liver and kidneys, and normalized to 0 mean 
and 1 standard-deviation. For each organ, the CT volumes were 
randomly divided into subsets to train (70%), validate (15%), 
and test (15%) the model. Splitting was performed by subject 
and separately for normal vs. diseased classes to preserve 
disease prevalence across each subset. Classification 
performance was based on the receiver operating characteristic 
(ROC) area under the curve (AUC). 
The 3D CNN used in this study was inspired by Resnet [24], 
Fig. 3(c) shows the 3D CNN architecture. One initial 
convolution was performed on input volumes, and then features 
were learned in three resolution scales using three R-blocks in 
each resolution. An R-block consists of batch-normalization, 
rectified linear unit (ReLu) activation, and 3D convolution.  
A deeper network has greater discriminative power due to the 
additional non-linearities and better quality of local optima 
[25]. However, convolutions with 3D kernels are 
computationally expensive and 3D architectures have a larger 
number of trainable parameters, thus 3x3x3 kernels were used 
to reduce computational cost and model complexity. Batch-
normalization allowed for standardization of the feature map 
activation at every optimization step. After each resolution, the 
features were halved by max-pooling and the number of filters 
were doubled. After the 3rd resolution, the last R-block features 
were passed through batch-normalization, ReLu, followed by a 
global max-pooling, dropout, and finally sigmoid classification 
layer for the final, multi-label predictions. 
Due to the computational expense it was not practical to feed 
the whole CT volume into 3D CNN. The final segmentation 
module was used to guide extraction of sub-volume patches for 
each target organ. We extracted a single patch of size 
224´160´160 (Z´W´H) for lungs/pleura and 96×128×128 
(Z´W´H) for both liver/gallbladder and kidneys from each 
volume using the segmented mask. Adam was used to optimize 
the weights, and weighted cross-entropy was used as the loss 
function. Initialization of the weights was done by uniform 
distribution. Training was continued for 100 epochs and only 
the weights for the lower loss on the validation set were saved. 
The same process was followed for each organ (lungs/pleura, 
 
(a) Framework of weakly supervised classification 
 
  
(b) Segmentation module architecture (c) Classification module architecture 
 
Fig. 3. (a) Illustration of framework of weakly supervised classification and CNN architectures. The proposed method consists 
of two separate modules for segmentation and classification. (b) The segmentation module is a DenseVNet, producing 
segmentation masks that were used to guide patch extraction for classification. (c) The classification module is a 3D Resnet-
like model with 3 R-Blocks in each resolution. Number of filters is denoted as 𝑓. Final output is a tensor of probabilities for 
desired Multi-classes. 
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liver/gallbladder, and kidneys). The model was implemented 
using Python TensorFlow framework. Training took 
approximately 26 hours for the segmentation module and 20 
hours for all three organ classification modules using 4 TITAN 
RTX GPUs. All models’ weights and code will be made 
publicly available upon publication 
(https://gitlab.oit.duke.edu/railabs). 
III. RESULTS 
The test set consisted of 2,158 (lungs/pleura=771, 
liver/gallbladder=652, kidneys=749) CT volumes from 2,133 
unique subjects with 1,154 labels for lungs/pleura, 787 labels 
for liver/gallbladder and 934 labels for kidneys. Label  
noise is an expected consequence of large and diverse medical 
imaging datasets. All 2,875 labels in the test set were manually 
validated and performed with accuracy from 91% to 99%, and 
F-score from 0.85 to 0.98. Table II displays the labeling 
accuracy for each organ and disease class.  
 Fig. 4 shows the performance of the multi-label 
classification models for the lungs/pleura, liver/gallbladder, and 
kidney when applied to the manually obtained test set shown in 
Table II. 
For the lungs/pleura, multi-label classification AUC was > 
0.8 for the diffuse lung diseases of effusion and emphysema, 
moderate for atelectasis with AUC of 0.77, but poor for nodules 
with AUC of 0.65. For liver/gallbladder, fatty liver and dilation 
demonstrated the highest performance with AUC > 0.8, liver 
lesion was moderate at 0.73, while the stone class performed 
poorly with < 0.7. For the kidneys, performance was good at 
AUC > 0.80 for kidney stone and atrophy classes, and moderate 
for kidney lesion (0.68) and cyst (0.70) classes. Examples of 
images that were classified by each of the classification 
modules are shown in Fig. 5 (a-h). 
IV. DISCUSSION 
The main purpose of this work was to investigate a weakly 
supervised 3D classification workflow that can be generalizable 
for the purpose of extracting multiple disease labels across 
TABLE II 
RBA PERFORMANCE FOR THE 2,158 RADIOLOGY REPORTS ACROSS THE 15 LABELS WITH MANUALLY OBTAINED GROUND TRUTH, “# POS” IS THE NUMBER OF 
POSITIVE EXAMPLES FOR THAT LABEL IN THE REPORT TEST SET, ACC=ACCURACY. 
   
Lungs/Pleura Liver/Gallbladder Kidneys 
Label # Pos Acc F-score Label # Pos Acc F-score Label # Pos Acc F-score 
Atelectasis 251 0.98 0.97 Stone 144 0.96 0.91 Stone 174 0.93 0.85 
Nodule 296 0.92 0.89 Lesion 224 0.95 0.92 Lesion 238 0.91 0.86 
Emphysema 193 0.99 0.98 Dilation 87 0.98 0.92 Atrophy 94 0.99 0.97 
Effusion 205 0.98 0.97 Fatty 166 0.98 0.96 Cyst 234 0.96 0.94 
Normal 209 0.98 0.96 Normal 166 0.96 0.93 Normal 194 0.96 0.92 
            
 
 
Fig. 4.  Test set AUCs of ROC curves for multi-label classification of CNNs for (left to right) lungs/pleura, liver/gallbladder, 
and kidney. Error Bar represents the 95% confidence interval (CI). 
 
6  
 
multiple organs in body CT. To test this hypothesis, we 
classified multiple diseases for lungs/pleura, liver/gallbladder, 
and kidneys. The organs and diseases were intentionally chosen 
to represent a wide variety of location and appearance. Unlike 
conventional methods which require well-annotated data and  
handcrafted features, the proposed system sought to formulate 
a RBA to analyze radiology text reports and avoid human 
annotation efforts. This provides a form of weak supervision 
since each case-level label (e.g., lung nodule) applies to an 
entire organ, although the disease may be present in only a 
portion of the volume.  
Weak supervision offers a number of general advantages. By 
using automated label extraction, we were able to quickly and 
easily label a vast data set from a large health system. Such a 
scalable approach allows better representation of a diverse 
patient population, scanner equipment/protocols, and 
organs/diseases. In contrast, manually curating and labeling 
such a large number of cases would be prohibitive in terms of 
time and expense. 
Many of the existing studies in medical image analysis have 
focused on a single abnormality or organ system [3-9],[19]. To 
the best of our knowledge, we are one of the first to gather such 
a diverse dataset with 15 possible labels (12 abnormalities, and 
3 normal labels for the lungs/pleura, liver/gallbladder, and 
kidneys) from a large data set of over 14,000 body CT scans 
from over 11,000 unique subjects. Similar studies like Wang et 
al.[11] explored a multi disease classifier for 8 common thorax 
diseases in 2D chest radiography, and Draelos et al. [19] 
classified CTs with 83 abnormalities in the chest. While those 
studies were limited to the chest region, our study investigated 
a weak-supervision approach to other organs in the abdomen 
and pelvis. Our lung multi-class classification results are most 
comparable to the Draelos et al. [19] CT-Net-9 multi-label 
model trained with 9 abnormalities: nodule 0.65 vs. 0.68, 
atelectasis 0.77 vs 0.68, and pleural effusion 0.97 vs. 0.94 for 
our model versus CT-Net-9, respectively. 
    
    
(a) L: Nodule, Emphysema (b) L: Atelectasis, Effusion (c) L: Nodule (d) L: Liver Lesion 
Atelectasis 0.23 Atelectasis 0.67 Atelectasis 0.39 Stone 0.29 
Nodule 0.42 Nodule 0.19 Nodule 0.40 Lesion 0.82 
Emphysema 0.82 Emphysema 0.01 Emphysema 0.34 Dilation 0.49 
Effusion 0.13 Effusion 0.92 Effusion 0.71 Fatty 0.01 
Normal 0.01 Normal 0.01 Normal 0.01 Normal 0.01 
 
    
(e)  L: Fatty Liver (f) L: Kidney Stone (g) L: Kidney Stone, Lesion, Cyst (h) L: Kidney Lesion, Atrophy 
Stone 0.02 Stone 0.86 Stone 0.32 Stone 0.12 
Lesion 0.08 Lesion 0.10 Lesion 0.26 Lesion 0.18 
Dilation 0.01 Atrophy 0.10 Atrophy 0.11 Atrophy 0.84 
Fatty 0.96 Cyst 0.13 Cyst 0.32 Cyst 0.20 
Normal 0.01 Normal 0.02 Normal 0.06 Normal 0.03 
        
Fig. 5.  Examples of CT volumes and multi-label outputs. Ground truth labels are listed below each image, followed by 
predicted probabilities for each multi-label class. L= Label. 
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Compared to 2D CNN, working with the 3D CNNs is 
computationally very expensive, especially for CT volumes that 
can be 512x512x1000. For this study, we downsampled the data 
to voxels of size 2 mm ´ 2 mm ´ 2 mm 	to allow a reasonable 
balance between batch vs. patch sizes. This decreased 
resolution may account for the poor performance for focal 
disease like lung nodules, compared to diffuse disease like 
atelectasis and effusion. This trend was also observed for the 
liver/gallbladder and kidneys. Diffuse diseases such as fatty 
liver or renal atrophy performed well, while focal diseases such 
as gallstones and kidney lesions performed poorly. There were 
a few notable exceptions, such as kidney stones that performed 
well with AUC > 0.8, which likely reflected the relative ease of 
detection because the CT scans for these kidney cases tended to 
be from specialized kidney stone detection protocols. 
Our first attempt towards multi-organ, multi-disease 
classification using radiology text reports has several 
limitations. This was a single institution study, and although the 
health system is composed of multiple hospitals, the patient 
population largely draws from a single geographic region, and 
reporting tendencies are likely to overlap amongst radiologists 
from the same department. With multi-label classification, the 
task of learning discriminative features for several co-occurring 
diseases provides the challenge of exponentially more 
possibilities than the more common binary tasks such as normal 
vs. abnormal or disease presence vs. absence. Additionally, our 
labels are inherently noisy. We considered only a few common 
abnormalities, but co-occurrence with other diseases could have 
confounded our results. Moreover, while our dataset represents 
the natural prevalence of disease in our study population, it 
demonstrates notable class imbalance. Finally, the complexity 
of sentences, diversity of expression in free-text narration, and 
typographical errors result in inevitable errors in our rule-based 
labeling, especially when considering that 2-20% of radiology 
text reports are estimated to contain demonstrable errors [26]  
Our future work will investigate important data extraction 
issues such as the relationship of CT resolution on classification 
performance. As a key step towards developing a universal 
abnormality detector, it will be necessary to understand the 
relationship between different, co-occurring abnormalities, 
including those with overlapping radiologic appearance such as 
pneumonia vs. atelectasis. We also observed that the 
segmentation performance was worse for the minority of cases 
without iodine contrast enhancement. In the future, it will be 
advantageous to augment the training data with less common 
cases acquired without contrast or with lower dose protocols, or 
even cases with known image artifacts. This will enrich the 
training and improve the generalization of the system. 
Overall, weak supervision offers a number of general 
advantages. By using automated label extraction, we were able 
to label a vast data set from a large health system, which in turn 
enabled the development of image classifiers for multiple 
organs and multiple diseases. Such a scalable approach is a step 
closer to satiating data-hungry deep learning models for 
medical imaging, where manually curating and labeling tens of 
thousands of cases would be prohibitive in terms of time and 
expense.  
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